CD276 and lymphoid neoplasm: In addition, CD276 expression was found to be higher in sarcoma (SARC), skin cutaneous melanoma (SKCM), GBM and lung squamous cell carcinoma (LUSC), but lower in LAML, thymoma (THYM) and lymphoid neoplasm diffuse large B-cell lymphoma (DLBC) for tumor tissues in TCGA (Fig. 3B), whereas markedly higher expression levels of CD276 were identified in the uterus, prostate and skin tissue for normal tissues in the GTEx cohort, with CD276 expression being the lowest in the thymus and pancreas (Fig. 3C).